Treventis Corporation
PrivateLast Round
Grant
Oct 18, 2022
Total Funding Raised
$8.42M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Treventis Corporation is a biotechnology company that develops disease-modifying small molecule drugs for protein misfolding diseases like Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treventis Corporation Comparables
Compare Treventis Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oligomerix, Inc. | 88% | |
| WaveBreak Therapeutics | 84% | |
| Aquinnah Pharmaceuticals | 84% | |
Treventis Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 18, 2022 | ||||
| Grant | Sep 19, 2013 |
Key People
Founding team and executive leadership
Treventis Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of War | Grant |
| BioAdvance Capital | Seed |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 82% MoM.
- May 20, 2026
Monthly visitors grew 84% MoM, from 785 to 1.4K.
Treventis Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Treventis Corporation's valuation, stock price, and market status.